Bronnen:
Bartosik-Psujek H, et al. Cladribine tablets versus other disease-modifying oral treatments in multiple sclerosis (MS) in achieving no evidence of radiological and clinical disease activity (NEDA) - network meta-analysis (NMA). Abstract P1070. ECTRIMS 11-13 sept 2019, Stockholm, Zweden. ECTRIMS 2019, P1390.
Bartosik-Psujek H, et al. Cladribine tablets versus other disease-modifying oral treatments in multiple sclerosis (MS) in achieving no evidence of radiological and clinical disease activity (NEDA) - network meta-analysis (NMA). Abstract P1070. ECTRIMS 11-13 sept 2019, Stockholm, Zweden. ECTRIMS 2019, P1390.